Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium and Cord Blood Cells for Acute/Sub-acute Spinal Cord Injury
NCT01471613Phase 2Completed
- Sponsor
- China Spinal Cord Injury Network
- Start
- Sep 2011
- Primary completion
- Dec 2013
- Modality
- DNA Intercalators/Alkylators, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate, umbilical cord blood mononuclear cells in spinal cord injury (SCI), sponsored by China Spinal Cord Injury Network. Started Sep 2011; status: completed.
02
Drugs
lithium carbonateumbilical cord blood mononuclear cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT01471613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471613.